Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1973 1
2001 1
2011 1
2012 3
2013 1
2014 1
2016 1
2017 3
2018 7
2019 8
2020 7
2021 6
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, McCracken L, Martinez-Hernandez E, Mason WP, Kruer MC, Ritacco DG, Grisold W, Meaney BF, Alcalá C, Sillevis-Smitt P, Titulaer MJ, Balice-Gordon R, Graus F, Dalmau J. Petit-Pedrol M, et al. Among authors: alcala c. Lancet Neurol. 2014 Mar;13(3):276-86. doi: 10.1016/S1474-4422(13)70299-0. Epub 2014 Jan 22. Lancet Neurol. 2014. PMID: 24462240 Free PMC article.
Cervical Tuberculous Lymphadenitis.
Pacifique M, Alcala C, Bryant SM. Pacifique M, et al. Among authors: alcala c. J Emerg Med. 2018 Jun;54(6):e141-e142. doi: 10.1016/j.jemermed.2018.02.004. Epub 2018 Mar 6. J Emerg Med. 2018. PMID: 29523421 No abstract available.
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.
Alcalá C, Quintanilla-Bordás C, Gascón F, Sempere ÁP, Navarro L, Carcelén-Gadea M, Landete L, Mallada J, Cañizares E, Belenguer A, Carratalá S, Domínguez JA, Pérez-Miralles FC, Gil-Perotín S, Gasqué R, Cubas L, Castillo J, Casanova B. Alcalá C, et al. J Neurol. 2022 Jul;269(7):3676-3681. doi: 10.1007/s00415-022-10989-0. Epub 2022 Feb 2. J Neurol. 2022. PMID: 35107597
An applied environmental justice framework for exposure science.
Van Horne YO, Alcala CS, Peltier RE, Quintana PJE, Seto E, Gonzales M, Johnston JE, Montoya LD, Quirós-Alcalá L, Beamer PI. Van Horne YO, et al. Among authors: alcala cs. J Expo Sci Environ Epidemiol. 2022 Mar 8:1-11. doi: 10.1038/s41370-022-00422-z. Online ahead of print. J Expo Sci Environ Epidemiol. 2022. PMID: 35260805 Free PMC article. Review.
Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis.
Brändle SM, Cerina M, Weber S, Held K, Menke AF, Alcalá C, Gebert D, Herrmann AM, Pellkofer H, Gerdes LA, Bittner S, Leypoldt F, Teegen B, Komorowski L, Kümpfel T, Hohlfeld R, Meuth SG, Casanova B, Melzer N, Beltrán E, Dornmair K. Brändle SM, et al. Among authors: alcala c. Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):e1916337118. doi: 10.1073/pnas.1916337118. Proc Natl Acad Sci U S A. 2021. PMID: 33619082 Free PMC article.
Silent Progression or Bout Onset Progressive Multiple Sclerosis?
Gil-Perotin S, Alcalá C, Pérez-Miralles FC, Casanova B. Gil-Perotin S, et al. Among authors: alcala c. Ann Neurol. 2019 Sep;86(3):472. doi: 10.1002/ana.25537. Epub 2019 Jul 12. Ann Neurol. 2019. PMID: 31251817 No abstract available.
47 results